Effect of an antidopaminergic drug on LH, FSH and PRL levels in post-menopausal women

P. L. Venturini; M. P. Alibrandi; S. Costantini; A. Grondona; S. Morano; L. Penna; M. Valenzano; N. Ragni

Effect of an antidopaminergic drug on LH, FSH and PRL levels in post-menopausal women

P. L. Venturini, M. P. Alibrandi, S. Costantini, A. Grondona, S. Morano, L. Penna, M. Valenzano, N. Ragni

A.O.U. San Martino - IST, Istituto Nazionale Ricerca sul Cancro (GENOVA)

Research output: Contribution to journal › Article › peer-review

Abstract

Natural or synthetic estrogens are the most common treatment of menopausal syndrome. One of the most unpleasant symptoms is vasomotor instability which results in characteristic 'hot flushes'. Catecholamines seem to play a role in producing this symptom. Veralipride is a new benzamine derivative, which showed a central antidopaminergic effect. We studied this drug in the treatment of the menopausal syndrome, because there is more evidence of neuroendocrinologic factor, related to changes in catecholamines in 'hot flushes'.

Original language	English
Pages (from-to)	293-294
Number of pages	2
Journal	Acta Europaea Fertilitatis
Volume	12
Issue number	3
Publication status	Published - 1981

ASJC Scopus subject areas

Obstetrics and Gynaecology

Fingerprint Dive into the research topics of 'Effect of an antidopaminergic drug on LH, FSH and PRL levels in post-menopausal women'. Together they form a unique fingerprint.

Cite this

@article{ebbc95addf48484494ab32d46b9bbc1e,

title = "Effect of an antidopaminergic drug on LH, FSH and PRL levels in post-menopausal women",

abstract = "Natural or synthetic estrogens are the most common treatment of menopausal syndrome. One of the most unpleasant symptoms is vasomotor instability which results in characteristic 'hot flushes'. Catecholamines seem to play a role in producing this symptom. Veralipride is a new benzamine derivative, which showed a central antidopaminergic effect. We studied this drug in the treatment of the menopausal syndrome, because there is more evidence of neuroendocrinologic factor, related to changes in catecholamines in 'hot flushes'.",

author = "Venturini, {P. L.} and Alibrandi, {M. P.} and S. Costantini and A. Grondona and S. Morano and L. Penna and M. Valenzano and N. Ragni",

year = "1981",

language = "English",

volume = "12",

pages = "293--294",

journal = "Acta Europaea Fertilitatis",

issn = "0587-2421",

number = "3",

}

TY - JOUR

T1 - Effect of an antidopaminergic drug on LH, FSH and PRL levels in post-menopausal women

AU - Venturini, P. L.

AU - Alibrandi, M. P.

AU - Costantini, S.

AU - Grondona, A.

AU - Morano, S.

AU - Penna, L.

AU - Valenzano, M.

AU - Ragni, N.

PY - 1981

Y1 - 1981

N2 - Natural or synthetic estrogens are the most common treatment of menopausal syndrome. One of the most unpleasant symptoms is vasomotor instability which results in characteristic 'hot flushes'. Catecholamines seem to play a role in producing this symptom. Veralipride is a new benzamine derivative, which showed a central antidopaminergic effect. We studied this drug in the treatment of the menopausal syndrome, because there is more evidence of neuroendocrinologic factor, related to changes in catecholamines in 'hot flushes'.

AB - Natural or synthetic estrogens are the most common treatment of menopausal syndrome. One of the most unpleasant symptoms is vasomotor instability which results in characteristic 'hot flushes'. Catecholamines seem to play a role in producing this symptom. Veralipride is a new benzamine derivative, which showed a central antidopaminergic effect. We studied this drug in the treatment of the menopausal syndrome, because there is more evidence of neuroendocrinologic factor, related to changes in catecholamines in 'hot flushes'.

UR - http://www.scopus.com/inward/record.url?scp=0019804512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019804512&partnerID=8YFLogxK

M3 - Article

C2 - 6803504

AN - SCOPUS:0019804512

VL - 12

SP - 293

EP - 294

JO - Acta Europaea Fertilitatis

JF - Acta Europaea Fertilitatis

SN - 0587-2421

IS - 3

ER -